Get startedLog in
    Picture of Biosenic SA logo

    BIOS — Biosenic SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Biosenic Publishes New Evidence Of Beneficial Effects Of Arsenic Trioxide Treatment Supporting Clinical Trial For Systemic Sclerosis

    Picture of Biosenic SA logoBiosenic SA
    19/09/2023 07:14
    Sept 19 (Reuters) - Bone Therapeutics SA  BIOS.BR :
    * BIOSENIC PUBLISHES NEW EVIDENCE OF BENEFICIAL EFFECTS OF
ARSENIC
TRIOXIDE TREATMENT SUPPORTING CLINICAL TRIAL FOR SYSTEMIC
SCLEROSIS
    * ARSENIC TRIOXIDE (ATO) THERAPEUTIC POTENTIAL TO TREAT
SYSTEMIC
SCLEROSIS (SSC) IS NOW CONFIRMED IN A NEW PRECLINICAL MODEL -
FRA2- CHARACTERIZED BY SEVERE PULMONARY LESIONS

Source text for Eikon:  ID:nGNEbCQh6V 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Biosenic SA

    See all news